Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Therapeutic Product Regulatory Reforms Considered Down Under

This article was originally published in The Tan Sheet

Executive Summary

Australia's Therapeutic Goods Association plans to implement a number of regulations to update and streamline the existing framework for over-the-counter and prescription drugs as well as medical devices
Advertisement

Related Content

Australia, NZ Again Drop Plan For Joint Therapeutic Product Regulator
Australia, NZ Again Drop Plan For Joint Therapeutic Product Regulator
In Brief: Advertising Regulation, Vansen Consumer, Star Scientific
In Brief: Advertising Regulation, Vansen Consumer, Star Scientific
Australia switches chloramphenicol eye drops
Australia switches chloramphenicol eye drops
Australia switches chloramphenicol eye drops
Australia, New Zealand Postpone Plans For Joint Medicines Agency
Australia, New Zealand Postpone Plans For Joint Medicines Agency

Topics

Advertisement
UsernamePublicRestriction

Register

PS102567

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel